KM Financial Solutions | Moderna, largest biotech to go public, fails to impress in market debut
39209
post-template-default,single,single-post,postid-39209,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Moderna, largest biotech to go public, fails to impress in market debut

Moderna, largest biotech to go public, fails to impress in market debut

Moderna Inc’s shares fell as much
as 6 percent in an upsized market debut on Friday, taking a hit
from a broader selloff in the U.S. markets spurred by investors
fretting over an economic slowdown.

No Comments

Sorry, the comment form is closed at this time.